Dr. Reddy's Laboratories Limited (DRREDDY.NS)
INR 1109.5
(1.41%)
INR 1109.5
(1.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 12.91 Billion INR | 67.85% |
| 2022 | 7.69 Billion INR | -59.5% |
| 2021 | 18.99 Billion INR | 22.7% |
| 2020 | 15.47 Billion INR | -22.79% |
| 2019 | 20.04 Billion INR | -44.54% |
| 2018 | 36.15 Billion INR | -24.8% |
| 2017 | 48.07 Billion INR | 54.84% |
| 2016 | 31.04 Billion INR | 581.98% |
| 2015 | -6.44 Billion INR | -285.54% |
| 2014 | 3.47 Billion INR | -69.02% |
| 2013 | 11.2 Billion INR | -96.46% |
| 2012 | 316.23 Billion INR | 2149.49% |
| 2011 | 14.05 Billion INR | -21.41% |
| 2010 | 17.88 Billion INR | 120.54% |
| 2009 | 8.11 Billion INR | -42.5% |
| 2008 | 14.1 Billion INR | 16.15% |
| 2007 | 12.14 Billion INR | 78.88% |
| 2006 | 6.78 Billion INR | -75.18% |
| 2005 | 27.35 Billion INR | 523.4% |
| 2004 | -6.46 Billion INR | -66.49% |
| 2003 | -3.88 Billion INR | 43.95% |
| 2002 | -6.92 Billion INR | -39.81% |
| 2001 | -4.95 Billion INR | -243.07% |
| 2000 | 3.46 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 37.21 Billion INR | 44.44% |
| 2024 Q1 | 25.76 Billion INR | 99.5% |
| 2023 Q3 | 12.5 Billion INR | 7869.57% |
| 2023 Q2 | -161 Million INR | -102.48% |
| 2023 FY | 12.91 Billion INR | 67.85% |
| 2023 Q4 | 12.91 Billion INR | 3.23% |
| 2023 Q1 | 6.5 Billion INR | -15.47% |
| 2022 Q4 | 7.69 Billion INR | -32.54% |
| 2022 FY | 7.69 Billion INR | -59.5% |
| 2022 Q3 | 11.4 Billion INR | 39.19% |
| 2022 Q1 | 18.64 Billion INR | -1.82% |
| 2022 Q2 | 8.19 Billion INR | -56.06% |
| 2021 Q2 | 20.29 Billion INR | -19.49% |
| 2021 FY | 18.99 Billion INR | 22.7% |
| 2021 Q1 | 25.2 Billion INR | 62.83% |
| 2021 Q4 | 18.99 Billion INR | 206.93% |
| 2021 Q3 | 6.18 Billion INR | -69.51% |
| 2020 Q3 | 16.12 Billion INR | -31.51% |
| 2020 Q4 | 15.47 Billion INR | -3.99% |
| 2020 FY | 15.47 Billion INR | -22.79% |
| 2020 Q1 | 27.18 Billion INR | 35.58% |
| 2020 Q2 | 23.54 Billion INR | -13.4% |
| 2019 Q2 | 28.53 Billion INR | -11.72% |
| 2019 Q3 | 14.07 Billion INR | -50.67% |
| 2019 FY | 20.04 Billion INR | -44.54% |
| 2019 Q4 | 20.04 Billion INR | 42.43% |
| 2019 Q1 | 32.32 Billion INR | -10.6% |
| 2018 Q2 | 51.74 Billion INR | -0.65% |
| 2018 Q1 | 52.08 Billion INR | 8.33% |
| 2018 Q4 | 36.15 Billion INR | -14.17% |
| 2018 Q3 | 42.12 Billion INR | -18.59% |
| 2018 FY | 36.15 Billion INR | -24.8% |
| 2017 Q4 | 48.07 Billion INR | -9.12% |
| 2017 FY | 48.07 Billion INR | 54.84% |
| 2017 Q3 | 52.9 Billion INR | 3.31% |
| 2017 Q2 | 51.2 Billion INR | 7.49% |
| 2017 Q1 | 47.63 Billion INR | 53.43% |
| 2016 Q3 | 51.96 Billion INR | -10.46% |
| 2016 Q2 | 58.03 Billion INR | 85.43% |
| 2016 Q4 | 31.04 Billion INR | -40.25% |
| 2016 Q1 | 31.29 Billion INR | 585.84% |
| 2016 FY | 31.04 Billion INR | 581.98% |
| 2015 Q2 | 30.39 Billion INR | -13.42% |
| 2015 Q4 | -6.44 Billion INR | -123.09% |
| 2015 Q1 | 35.1 Billion INR | 911.06% |
| 2015 FY | -6.44 Billion INR | -285.54% |
| 2015 Q3 | 27.89 Billion INR | -8.21% |
| 2014 FY | 3.47 Billion INR | -69.02% |
| 2014 Q3 | 33.37 Billion INR | 8.94% |
| 2014 Q2 | 30.63 Billion INR | -13.23% |
| 2014 Q1 | 35.3 Billion INR | 215.02% |
| 2014 Q4 | 3.47 Billion INR | -89.6% |
| 2013 Q3 | 28.11 Billion INR | -25.44% |
| 2013 Q1 | 34.91 Billion INR | -88.96% |
| 2013 Q4 | 11.2 Billion INR | -60.13% |
| 2013 Q2 | 37.7 Billion INR | 7.98% |
| 2013 FY | 11.2 Billion INR | -96.46% |
| 2012 FY | 316.23 Billion INR | 2149.49% |
| 2012 Q4 | 316.23 Billion INR | 1027.68% |
| 2012 Q2 | 27.92 Billion INR | 3.55% |
| 2012 Q1 | 26.96 Billion INR | 91.81% |
| 2012 Q3 | 28.04 Billion INR | 0.43% |
| 2011 FY | 14.05 Billion INR | -21.41% |
| 2011 Q4 | 14.05 Billion INR | -35.85% |
| 2011 Q3 | 21.91 Billion INR | -7.56% |
| 2011 Q2 | 23.7 Billion INR | 28.34% |
| 2011 Q1 | 18.47 Billion INR | 3.26% |
| 2010 Q1 | 7.5 Billion INR | -7.46% |
| 2010 Q3 | 9.68 Billion INR | 16.68% |
| 2010 Q4 | 17.88 Billion INR | 84.76% |
| 2010 FY | 17.88 Billion INR | 120.54% |
| 2010 Q2 | 8.29 Billion INR | 10.55% |
| 2009 Q3 | 7.13 Billion INR | -16.26% |
| 2009 Q1 | 9.92 Billion INR | -29.64% |
| 2009 Q4 | 8.11 Billion INR | 13.69% |
| 2009 Q2 | 8.51 Billion INR | -14.16% |
| 2009 FY | 8.11 Billion INR | -42.5% |
| 2008 FY | 14.1 Billion INR | 16.15% |
| 2008 Q4 | 14.1 Billion INR | -23.67% |
| 2008 Q1 | 15.12 Billion INR | 24.57% |
| 2008 Q2 | 17.06 Billion INR | 12.83% |
| 2008 Q3 | 18.48 Billion INR | 8.27% |
| 2007 Q4 | 12.14 Billion INR | 12.05% |
| 2007 Q3 | 10.83 Billion INR | 37.36% |
| 2007 Q2 | 7.89 Billion INR | 87.63% |
| 2007 Q1 | 4.2 Billion INR | -38.05% |
| 2007 FY | 12.14 Billion INR | 78.88% |
| 2006 Q3 | 11.28 Billion INR | -58.79% |
| 2006 Q4 | 6.78 Billion INR | -39.86% |
| 2006 Q1 | 29.9 Billion INR | 9.32% |
| 2006 FY | 6.78 Billion INR | -75.18% |
| 2006 Q2 | 27.39 Billion INR | -8.4% |
| 2005 FY | 27.35 Billion INR | 523.4% |
| 2005 Q3 | -4.28 Billion INR | 33.4% |
| 2005 Q4 | 27.35 Billion INR | 738.94% |
| 2005 Q1 | -6.41 Billion INR | 0.68% |
| 2005 Q2 | -6.42 Billion INR | -0.17% |
| 2004 Q4 | -6.46 Billion INR | -76.52% |
| 2004 FY | -6.46 Billion INR | -66.49% |
| 2004 Q1 | -1.75 Billion INR | 54.65% |
| 2004 Q3 | -3.65 Billion INR | 10.05% |
| 2004 Q2 | -4.06 Billion INR | -131.23% |
| 2003 Q1 | -7.43 Billion INR | -7.35% |
| 2003 Q4 | -3.88 Billion INR | 30.65% |
| 2003 Q2 | -7.43 Billion INR | -0.03% |
| 2003 Q3 | -5.59 Billion INR | 24.73% |
| 2003 FY | -3.88 Billion INR | 43.95% |
| 2002 FY | -6.92 Billion INR | -39.81% |
| 2002 Q3 | -6.69 Billion INR | -6.31% |
| 2002 Q4 | -6.92 Billion INR | -3.35% |
| 2002 Q1 | -6.09 Billion INR | -23.04% |
| 2002 Q2 | -6.3 Billion INR | -3.42% |
| 2001 FY | -4.95 Billion INR | -243.07% |
| 2001 Q1 | -2.61 Billion INR | 0.0% |
| 2001 Q2 | -2.72 Billion INR | -4.08% |
| 2001 Q4 | -4.95 Billion INR | -29.27% |
| 2001 Q3 | -3.83 Billion INR | -40.54% |
| 2000 FY | 3.46 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | -234.023% |
| Hester Biosciences Limited | 2.29 Billion INR | -463.704% |
| Aarti Drugs Limited | 5.54 Billion INR | -132.734% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | -394.391% |
| Albert David Limited | -278.36 Million INR | 4738.807% |
| Alembic Limited | 66.9 Million INR | -19201.943% |
| Alkem Laboratories Limited | -1.6 Billion INR | 902.349% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | -5515.984% |
| Bajaj HealthCare Limited | 3.29 Billion INR | -291.427% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 70104.337% |
| Brooks Laboratories Limited | 49.48 Million INR | -25994.776% |
| Eris Lifesciences Limited | 13.8 Billion INR | 6.471% |
| FDC Limited | -57.75 Million INR | 22459.399% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 554.258% |
| Gufic Biosciences Limited | 3.19 Billion INR | -304.249% |
| Hikal Limited | 7.96 Billion INR | -62.081% |
| Ind-Swift Limited | 9.5 Billion INR | -35.804% |
| Innova Captab Limited | 2.33 Billion INR | -453.313% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 1272.523% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 1029.04% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 52.301% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | 10216.893% |
| Lupin Limited | 19.38 Billion INR | 33.386% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -1223.31% |
| Medico Remedies Limited | 78.67 Million INR | -16312.675% |
| Morepen Laboratories Limited | -231.17 Million INR | 5685.836% |
| Nectar Lifesciences Limited | 6.15 Billion INR | -109.718% |
| Orchid Pharma Limited | -1.31 Billion INR | 1082.84% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 649.957% |
| RPG Life Sciences Limited | -364.7 Million INR | 3640.718% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -10657.337% |
| Sigachi Industries Limited | 859.94 Million INR | -1401.601% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | -28.721% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -8806.992% |
| Themis Medicare Limited | 764.96 Million INR | -1588.058% |
| Unichem Laboratories Limited | 931.91 Million INR | -1285.64% |
| Vaishali Pharma Limited | 119.13 Million INR | -10738.964% |
| Wanbury Limited | 1.1 Billion INR | -1067.673% |
| Windlas Biotech Limited | -273.04 Million INR | 4829.344% |
| ZIM Laboratories Limited | 983.6 Million INR | -1212.825% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 410.928% |
| Ipca Laboratories Limited | 11.41 Billion INR | -13.121% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 117.818% |
| Venus Remedies Limited | -267.7 Million INR | 4923.683% |
| Sakar Healthcare Limited | 790.93 Million INR | -1532.621% |
| Aurobindo Pharma Limited | 3.69 Billion INR | -249.633% |
| Divi's Laboratories Limited | -39.77 Billion INR | 132.469% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 357.619% |
| Mankind Pharma Limited | -1.74 Billion INR | 838.582% |
| Sequent Scientific Limited | 4.17 Billion INR | -209.025% |
| Laurus Labs Limited | 24.35 Billion INR | 46.986% |
| Neuland Laboratories Limited | -214.05 Million INR | 6132.477% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | -357.713% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 401.335% |
| Zydus Lifesciences Limited | 3.91 Billion INR | -230.087% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 5290.279% |
| Wockhardt Limited | 18.27 Billion INR | 29.321% |
| Bal Pharma Limited | 1.26 Billion INR | -921.953% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 1215.351% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | 3622.954% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 334.454% |
| Shilpa Medicare Limited | 9.06 Billion INR | -42.378% |
| Valiant Laboratories Limited | 649.9 Million INR | -1886.915% |
| Ajanta Pharma Limited | -954.9 Million INR | 1452.288% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | -4239.348% |
| Granules India Limited | 9.28 Billion INR | -39.047% |
| Medicamen Biotech Limited | 160.31 Million INR | -7954.717% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -27843.563% |
| Piramal Enterprises Limited | 491.39 Billion INR | 97.372% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 59.431% |
| NATCO Pharma Limited | -5.81 Billion INR | 321.987% |
| Suven Life Sciences Limited | -1.63 Billion INR | 890.899% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -568.056% |
| Strides Pharma Science Limited | 23.25 Billion INR | 44.477% |
| Indoco Remedies Limited | 6.47 Billion INR | -99.389% |
| Alpa Laboratories Limited | 35.36 Million INR | -36415.567% |
| Lasa Supergenerics Limited | 205.79 Million INR | -6174.569% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 1471.098% |